Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats

Hormones and Behavior

Volumn 60, Issue 5, 2011, Pages 607-616

  Gibbs, R B ^a   Chipman, A M ^a   Hammond, R ^a   Nelson, D ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Acetylcholine; Alzheimer's disease; Cholinesterase inhibitor; Cognitive aging; Hormone therapy; Nicotinic receptors; Spatial learning; Surgical menopause

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; ESTRADIOL; GALANTAMINE;

ACETYLCHOLINE RELEASE; AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; MAZE TEST; MOUSE; NONHUMAN; OVARIECTOMY; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; SPATIAL MEMORY; TASK PERFORMANCE; TRAINING;

ACETYLCHOLINE; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; CHOLINESTERASE INHIBITORS; COGNITION; DRUG THERAPY, COMBINATION; ESTRADIOL; FEMALE; GALANTAMINE; HIPPOCAMPUS; MAZE LEARNING; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80555131160     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2011.08.010     Document Type: Article

References (109)

1. Albuquerque E.X., Pereira E.F., Mike A., Eisenberg H.M., Maelicke A., Alkondon M. Neuronal nicotinic receptors in synaptic functions in humans and rats: physiological and clinical relevance. Behav. Brain Res. 2000, 113:131-141.
2. Albuquerque E.X., Pereira E.F., Alkondon M., Rogers S.W. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 2009, 89:73-120.
3. Altavista M.C., Rossi P., Bentivoglio A.R., Crociani P., Albanese A. Aging is associated with a diffuse impairment of forebrain cholinergic neurons. Brain Res. 1990, 508:51-59.
4. Araujo D.M., Lapchak P.A., Meaney M.J., Collier B., Quirion R. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites. J. Neurosci. 1990, 10:3069-3078.
5. Arrigoni E., Mochizuki T., Scammell T.E. Activation of the basal forebrain by the orexin/hypocretin neurones. Acta Physiol. (Oxf.) 2010, 198:223-235.
6. Aston-Jones G., Smith R.J., Sartor G.C., Moorman D.E., Massi L., Tahsili-Fahadan P., Richardson K.A. Lateral hypothalamic orexin/hypocretin neurons: a role in reward-seeking and addiction. Brain Res. 2010, 1314:74-90.
7. Barnes C.A., Nadel L., Honig W.K. Spatial memory deficit in senescent rats. Can. J. Psychol. 1980, 34:29-39.
8. Baskerville K.A., Kent C., Nicolle M.M., Gallagher M., McKinney M. Aging causes partial loss of basal forebrain but no loss of pontine reticular cholinergic neurons. Neuroreport 2006, 17:1819-1823.
9. Bohacek J., Bearl A.M., Daniel J.M. Long-term ovarian hormone deprivation alters the ability of subsequent oestradiol replacement to regulate choline acetyltransferase protein levels in the hippocampus and prefrontal cortex of middle-aged rats. J. Neuroendocrinol. 2008, 20:1023-1027.
10. Chang Q., Savage L.M., Gold P.E. Microdialysis measures of functional increases in ACh release in the hippocampus with and without inclusion of acetylcholinesterase inhibitors in the perfusate. J. Neurochem. 2006, 97:697-706.
11. Cincotta S.L., Yorek M.S., Moschak T.M., Lewis S.R., Rodefer J.S. Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction. Curr. Opin. Investig. Drugs 2008, 9:47-56.
12. Cutuli D., Foti F., Mandolesi L., De Bartolo P., Gelfo F., Federico F., Petrosini L. Cognitive performances of cholinergically depleted rats following chronic donepezil administration. J. Alzheimers Dis. 2009, 17:161-176.
13. Daniel J.M., Bohacek J. The critical period hypothesis of estrogen effects on cognition: mnsights from basic research. Biochim. Biophys. Acta 2010, 1800:1068-1076.
14. Daniel J.M., Dohanich G.P. Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory. J. Neurosci. 2001, 21:6949-6956.
15. Daniel J.M., Hulst J.L., Lee C.D. Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory. Neuroscience 2005, 132:57-64.
16. Daniel J.M., Hulst J.L., Berbling J.L. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology 2006, 147:607-614.
17. Darreh-Shori T., Meurling L., Pettersson T., Hugosson K., Hellstrom-Lindahl E., Andreasen N., Minthon L., Nordberg A. Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment. J. Neural Transm. 2006, 113:1791-1801.
18. Davidsson P., Blennow K., Andreasen N., Eriksson B., Minthon L., Hesse C. Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease. Neurosci. Lett. 2001, 300:157-160.
19. Davis B., Sadik K. Circadian cholinergic rhythms: implications for cholinesterase inhibitor therapy. Dement. Geriatr. Cogn. Disord. 2006, 21:120-129.
20. de Lecea L. A decade of hypocretins: past, present and future of the neurobiology of arousal. Acta Physiol. (Oxf.) 2010, 198:203-208.
21. Eggermann E., Serafin M., Bayer L., Machard D., Saint-Mleux B., Jones B.E., Muhlethaler M. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 2001, 108:177-181.
22. Ellman G.L., Courtney K.D., Andres V.A., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
23. Espana R.A., Baldo B.A., Kelley A.E., Berridge C.W. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 2001, 106:699-715.
24. Espana R.A., Reis K.M., Valentino R.J., Berridge C.W. Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. J. Comp. Neurol. 2005, 481:160-178.
25. Fadel J., Frederick-Duus D. Orexin/hypocretin modulation of the basal forebrain cholinergic system: insights from in vivo microdialysis studies. Pharmacol. Biochem. Behav. 2008, 90:156-162.
26. Fadel J., Pasumarthi R., Reznikov L.R. Stimulation of cortical acetylcholine release by orexin A. Neuroscience 2005, 130:541-547.
27. Fernandez S.M., Lewis M.C., Pechenino A.S., Harburger L.L., Orr P.T., Gresack J.E., Schafe G.E., Frick K.M. Estradiol-induced enhancement of object memory consolidation involves hippocampal extracellular signal-regulated kinase activation and membrane-bound estrogen receptors. J. Neurosci. 2008, 28:8660-8667.
28. Fischer W., Gage F.H., Björklund A. Degenerative changes in forebrain cholinergic nuclei correlate with cognitive impairments in aged rats. Eur. J. Neurosci. 1989, 1:34-45.
29. Fischer W., Chen K.S., Gage F.H., Bjorklund A. Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol. Aging 1992, 13:9-23.
30. Fischer W., Chen K.S., Gage F.H., Bjorklund A. Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol. Aging 1992, 13:9-23.
31. Fitz N.F., Gibbs R.B., Johnson D.A. Aversive stimulus attenuates impairment of acquisition in a delayed match to position T-maze task caused by a selective lesion of septo-hippocampal cholinergic projections. Brain Res. Bull. 2006, 69:660-665.
32. Fitz N.F., Gibbs R.B., Johnson D.A. Selective lesion of septal cholinergic neurons in rats impairs acquisition of a delayed matching to position T-maze task by delaying the shift from a response to a place strategy. Brain Res. Bull. 2008, 77:356-360.
33. Frederick-Duus D., Guyton M.F., Fadel J. Food-elicited increases in cortical acetylcholine release require orexin transmission. Neuroscience 2007, 149:499-507.
34. Gabor R., Nagle R., Johnson D.A., Gibbs R.B. Estrogen enhances potassium-stimulated acetylcholine release in the rat hippocampus. Brain Res. 2003, 962:244-247.
35. Geerts H., Guillaumat P.O., Grantham C., Bode W., Anciaux K., Sachak S. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits. Brain Res. 2005, 1033:186-193.
36. Gibbs R.B. Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res. 1997, 757:10-16.
37. Gibbs R.B. Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 2000, 101:931-938.
38. Gibbs R.B. Estradiol enhances DMP acquisition via a mechanism not mediated by turning strategy but which requires intact basal forebrain cholinergic projections. Horm. Behav. 2007, 52:352-359.
39. Gibbs R.B. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr. Rev. 2010, 31:224-253.
40. Gibbs R.B., Johnson D.A. Cholinergic lesions produce task-selective effects on delayed matching to position and configural association learning related to response pattern and strategy. Neurobiol. Learn. Mem. 2007, 88:19-32.
41. Gibbs R.B., Hashash A., Johnson D.A. Effects of estrogen on potassium-stimulated acetylcholine release in the hippocampus and overlying cortex of adult rats. Brain Res. 1997, 749:143-146.
42. Gibbs R.B., Gabor R., Cox T., Johnson D.A. Effects of raloxifene and estradiol on hippocampal acetylcholine release and spatial learning in the rat. Psychoneuroendocrinology 2004, 29:741-748.
43. Gibbs R.B., Mauk R., Nelson D., Johnson D.A. Donepezil treatment restores the ability of estradiol to enhance cognitive performance in aged rats: evidence for the cholinergic basis of the critical period hypothesis. Horm. Behav. 2009, 56:73-83.
44. Gibbs R.B., Chipman A.M., Nelson D. Donepezil plus estradiol treatment enhances learning and delay-dependent memory performance by young ovariectomized rats with partial loss of septal cholinergic neurons. Horm. Behav. 2011, 59(4):503-511.
45. Iso H., Ueki A., Shinjo H., Miwa C., Morita Y. Reinforcement enhances hippocampal acetylcholine release in rats: an in vivo microdialysis study. Behav. Brain Res. 1999, 101:207-213.
46. Jürgensen S., Ferreira S.T. Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease. J. Mol. Neurosci. 2009, 40(1-2):221-229.
47. Kristofiková Z., Klaschka J., Tejkalová H., Benesová O. High-affinity choline uptake and muscarinic receptors in rat brain during aging. Arch. Gerontol. Geriatr. 1992, 15:87-97.
48. Lam T.T., Leranth C. Role of the medial septum diagonal band of Broca cholinergic neurons in oestrogen-induced spine synapse formation on hippocampal CA1 pyramidal cells of female rats. Eur. J. Neurosci. 2003, 17:1997-2005.
49. Lanari A., Amenta F., Silvestrelli G., Tomassoni D., Parnetti L. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease. Mech. Ageing Dev. 2006, 127:158-165.
50. Levin E.D., Rezvani A.H. Nicotinic treatment for cognitive dysfunction. Curr. Drug Targets CNS Neurol. Disord. 2002, 1:423-431.
51. Levin E.D., McClernon F.J., Rezvani A.H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 2006, 184:523-539.
52. Lindstrom J. Nicotinic acetylcholine receptors in health and disease. Mol. Neurobiol. 1997, 15:193-222.
53. Linstow E., Platt B. Biochemical dysfunction and memory loss: the case of Alzheimer's dementia. Cell. Mol. Life Sci. 1999, 55:601-616.
54. Luine V.N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 1985, 89:484-490.
55. Maelicke A., Schrattenholz A., Samochocki M., Radina M., Albuquerque E.X. Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease. Behav. brain Res. 2000, 113:199-206.
56. Maki P.M. Hormone therapy and cognitive function: is there a critical period for benefit?. Neuroscience 2006, 138:1027-1030.
57. Markowska A.L., Savonenko A.V. Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J. Neurosci. 2002, 22:10985-10995.
58. Marriott L.K., Korol D.L. Short-term estrogen treatment in ovariectomized rats augments hippocampal acetylcholine release during place learning. Neurobiol. Learn. Mem. 2003, 80:315-322.
59. McIntyre C.K., Marriott L.K., Gold P.E. Patterns of brain acetylcholine release predict individual differences in preferred learning strategies in rats. Neurobiol. Learn. Mem. 2003, 79:177-183.
60. Mesulam M.M., Mufson E.J., Rogers J. Age-related shrinkage of cortically projecting cholinergic neurons: a selective effect. Ann. Neurol. 1987, 22:31-36.
61. Moore H., Stuckman S., Sarter M., Bruno J.P. Potassium, but not atropine-stimulated cortical acetylcholine efflux, is reduced in aged rats. Neurobiol. Aging 1996, 17:565-571.
62. Nishino S. Hypothalamus, hypocretins/orexin, and vigilance control. Handb. Clin. Neurol. 2011, 99:765-782.
63. Nordberg A., Hellström-Lindahl E., Almkvist O., Meurling L. Activity of acetylcholinesterase in CSF increases in Alzheimer's patients after treatment with tacrine. Alzheimers Rep. 1999, 2:347-352.
64. Orsetti M., Casamenti F., Pepeu G. Enhanced acetylcholine release in the hippocampus and cortex during acquisition of an operant behavior. Brain Res. 1996, 724:89-96.
65. Parikh V., Sarter M. Cholinergic mediation of attention: contributions of phasic and tonic increases in prefrontal cholinergic activity. Ann. N. Y. Acad. Sci. 2008, 1129:225-235.
66. Parikh V., Kozak R., Martinez V., Sarter M. Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron 2007, 56:141-154.
67. Paxinos G., Watson C. The Rat Brain in Stereotaxic Atlas 1986, Academic Press, London.
68. Pekkala S., Albert M.L., Spiro A., Erkinjuntti T. Perseveration in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2008, 25:109-114.
69. Pepeu G., Giovannini M.G. Cholinesterase inhibitors and memory. Chem. Biol. Interact. 2010, 187:403-408.
70. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18:9996-10015.
71. Porkka-Heiskanen T., Kalinchuk A., Alanko L., Huhtaniemi I., Stenberg D. Orexin A and B levels in the hypothalamus of female rats: the effects of the estrous cycle and age. Eur. J. Endocrinol. 2004, 150:737-742.
72. Pych J.C., Chang Q., Colon-Rivera C., Gold P.E. Acetylcholine release in hippocampus and striatum during testing on a rewarded spontaneous alternation task. Neurobiol. Learn. Mem. 2005, 84:93-101.
73. Resnick S.M., Maki P.M., Rapp S.R., Espeland M.A., Brunner R., Coker L.H., Granek I.A., Hogan P., Ockene J.K., Shumaker S.A. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J. Clin. Endocrinol. Metab. 2006, 91:1802-1810.
74. Rhodes M.E., Li P.K., Flood J.F., Johnson D.A. Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: an in vivo microdialysis study. Brain Res. 1996, 733:284-286.
75. Rudick C.N., Gibbs R.B., Woolley C.S. A role for the basal forebrain cholinergic system in estrogen-induced disinhibition of hippocampal pyramidal cells. J. Neurosci. 2003, 23:4479-4490.
76. Sakurai T., Mieda M., Tsujino N. The orexin system: roles in sleep/wake regulation. Ann. N. Y. Acad. Sci. 2010, 1200:149-161.
77. Samochocki M., Hoffle A., Fehrenbacher A., Jostock R., Ludwig J., Christner C., Radina M., Zerlin M., Ullmer C., Pereira E.F., Lubbert H., Albuquerque E.X., Maelicke A. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 2003, 305:1024-1036.
78. Sandstrom N.J., Williams C.L. Memory retention is modulated by acute estradiol and progesterone replacement. Behav. Neurosci. 2001, 115:384-393.
79. Sandstrom N.J., Williams C.L. Spatial memory retention is enhanced by acute and continuous estradiol replacement. Horm. Behav. 2004, 45:128-135.
80. Santos M.D., Alkondon M., Pereira E.F., Aracava Y., Eisenberg H.M., Maelicke A., Albuquerque E.X. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Mol. Pharmacol. 2002, 61:1222-1234.
81. Sapronov N.S., Fedotova Y.O., Kuznetsova N.N. Antiamnestic effect of alpha7-nicotinic receptor agonist RJR-2403 in middle-aged ovariectomized rats with Alzheimer type dementia. Bull. Exp. Biol. Med. 2006, 142:700-702.
82. Sarter M., Parikh V., Howe W.M. nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms. Biochem. Pharmacol. 2009, 78:658-667.
83. Schilstrom B., Ivanov V.B., Wiker C., Svensson T.H. Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors. Neuropsychopharmacology 2006, 32(1):43-53.
84. Schliebs R., Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J. Neural. Transm. 2006, 113:1625-1644.
85. Sherman K.A., Friedman E. Pre- and post-synaptic cholinergic dysfunction in aged rodent brain regions: new findings and an interpretative review. Int. J. Dev. Neurosci. 1990, 8:689-708.
86. Sherwin B.B. Estrogen therapy: is time of initiation critical for neuroprotection?. Nat. Rev. Endocrinol. 2009, 5:620-627.
87. Sherwin B.B., Henry J.F. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front. Neuroendocrinol. 2008, 29:88-113.
88. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. Jama 2003, 289:2651-2662.
89. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., Fillit H., Stefanick M.L., Hendrix S.L., Lewis C.E., Masaki K., Coker L.H. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Jama 2004, 291:2947-2958.
90. Shuster L.T., Rhodes D.J., Gostout B.S., Grossardt B.R., Rocca W.A. Premature menopause or early menopause: long-term health consequences. Maturitas 2010, 65:161-166.
91. Singh M., Meyer E.M., Millard W.J., Simpkins J.W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 1994, 644:305-312.
92. Smith D.E., Roberts J., Gage F.H., Tuszynski M.H. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc. Natl. Acad Sci. U. S. A. 1999, 96:10893-10898.
93. Spencer J.L., Waters E.M., Romeo R.D., Wood G.E., Milner T.A., McEwen B.S. Uncovering the mechanisms of estrogen effects on hippocampal function. Front. Neuroendocrinol. 2008, 29:219-237.
94. Stroessner-Johnson H.M., Rapp P.R., Amaral D.G. Cholinergic cell loss and hypertrophy in the medial septal nucleus of the behaviorally characterized aged Rhesus monkey. J. Neurosci. 1992, 12:1936-1944.
95. Szekely M., Petervari E., Balasko M. Thermoregulation, energy balance, regulatory peptides: recent developments. Front. Biosci. (Schol. Ed.) 2010, 2:1009-1046.
96. Takei N., Nihonmatsu I., Kawamura H. Age-related decline of acetylcholinesterase release evoked by depolarizing stimulation. Neurosci. Lett. 1989, 101:182-186.
97. Talboom J.S., Williams B.J., Baxley E.R., West S.G., Bimonte-Nelson H.A. Higher levels of estradiol replacement correlate with better spatial memory in surgically menopausal young and middle-aged rats. Neurobiol. Learn. Mem. 2008, 90:155-163.
98. Taly A., Corringer P.J., Guedin D., Lestage P., Changeux J.P. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat. Rev. Drug Discov. 2009, 8:733-750.
99. Taylor L., Griffith W.H. Age-related decline in cholinergic synaptic transmission in hippocampus. Neurobiol. Aging 1993, 14:509-515.
100. Taylor G.T., Maloney S. Gender differences and the role of estrogen in cognitive enhancements with nicotine in rats. Pharmacol. Biochem. Behav. 2010, 95:139-145.
101. Thakkar M.M., Ramesh V., Strecker R.E., McCarley R.W. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch. Ital. Biol. 2001, 139:313-328.
102. Thomson T., Kewitz H., Bickel V., Straschill M., Holl G. Preclinical and clinical studies with galantamine. Cholinergic Basis of Alzheimer's Disease 1991, 328-336. Birhauser, Boston. R. Becker, E. Giacobini (Eds.).
103. Wallace M., Luine V., Arellanos A., Frankfurt M. Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex. Brain Res. 2006, 1126:176-182.
104. Wang V.C., Sable H.J., Ju Y.H., Allred C.D., Helferich W.G., Korol D.L., Schantz S.L. Effects of chronic estradiol treatment on delayed spatial alternation and differential reinforcement of low rates of responding. Behav. Neurosci. 2008, 122:794-804.
105. Wang V.C., Neese S.L., Korol D.L., Schantz S.L. Chronic estradiol replacement impairs performance on an operant delayed spatial alternation task in young, middle-aged, and old rats. Horm. Behav. 2009, 56:382-390.
106. Woodruff-Pak D.S., Vogel R.W., Wenk G.L. Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors. Neuroscience 2003, 117:439-447.
107. Woolley C.S. Acute effects of estrogen on neuronal physiology. Annu. Rev. Pharmacol. Toxicol. 2007, 47:657-680.
108. Wu C.F., Bertorelli R., Sacconi M., Pepeu G., Consolo S. Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. Neurobiol. Aging 1988, 9:357-361.
109. Wu M., Zaborszky L., Hajszan T., van den Pol A.N., Alreja M. Hypocretin/orexin innervation and excitation of identified septohippocampal cholinergic neurons. J. Neurosci. 2004, 24:3527-3536.